AtriCure traded at $42.50 this Tuesday July 5th, increasing $1.49 or 3.63 percent since the previous trading session. Looking back, over the last four weeks, AtriCure gained 1.77 percent. Over the last 12 months, its price fell by 46.76 percent. Looking ahead, we forecast AtriCure to be priced at 39.90 by the end of this quarter and at 36.74 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Abiomed 254.04 -2.62 -1.02% -22.24%
Abbott 108.40 -0.90 -0.82% -8.77%
AtriCure 42.50 1.49 3.63% -46.76%
Baxter International 65.38 -0.01 -0.02% -19.35%
Becton, Dickinson and Co. 247.81 -0.12 -0.05% -0.62%
Boston Scientific 37.75 -0.01 -0.03% -13.46%
Cooper Companies 316.15 0.26 0.08% -22.81%
Artivion Inc 19.39 0.18 0.94% -30.87%
Cardiovascular Systems 14.85 0.28 1.92% -65.09%
Dexcom 77.63 -0.84 -1.06% -82.38%
Edwards Lifesciences 96.79 -1.18 -1.20% -9.08%
Globus Medical 57.39 -0.33 -0.57% -28.26%
Integra LifeSciences 54.29 -0.71 -1.29% -21.27%
Inogen 25.09 0.59 2.41% -61.17%
Intuitive Surgical 205.74 -1.01 -0.49% -78.30%
J&J 178.30 0.16 0.09% 6.15%
Masimo 136.65 0.75 0.55% -46.88%
Medtronic 89.98 -0.51 -0.56% -29.13%
Merit Medical Systems 54.46 -0.50 -0.91% -14.48%
NuVasive 50.36 0.10 0.20% -24.68%
Insulet 231.68 5.22 2.31% -19.21%
ResMed 217.18 0.75 0.35% -12.40%
Stryker 201.41 -0.61 -0.30% -23.96%
Teleflex 251.29 -0.96 -0.38% -39.10%
Tandem Diabetes Care 63.23 1.42 2.30% -37.08%
Zimmer Biomet Holdings Inc 106.65 -0.24 -0.22% -34.48%

Indexes Price Day Year
USND 11322 194.39 1.75% -22.79%
US2000 1741 13.57 0.79% -23.44%

AtriCure
AtriCure, Inc. is a provider of technologies for the treatment of atrial fibrillation (Afib) and related conditions. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue, systems designed for the exclusion of the left atrial appendage, and devices designed to block pain by temporarily ablating peripheral nerves. These devices are developed and marketed to medical centers globally. Its ablation and left atrial appendage management (LAAM) products are used by physicians during both open-heart and minimally invasive procedures. Its products for open and minimally invasive ablation includes Isolator Synergy Clamp and Multifunctional Pens and Linear Ablation Devices. Its Product for open ablation are cryoICE Cryoablation System. Its product for minimally invasive ablation are EPi-Sense Guided Coagulation System with VisiTrax Technology. Its products for appendage management includes AtriClip System and LARIAT System.